Cystic fibrosis. Between normality and disability

被引:0
|
作者
Kappler, M. [1 ]
Griese, M. [1 ]
机构
[1] Univ Munich, Kinderklin & Kinderpoliklin, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany
关键词
Cystic fibrosis; Disability; Therapy burden; Quality of life; Interdisciplinary care; QUALITY-OF-LIFE; CHILDREN; DISEASE; CARE;
D O I
10.1007/s00112-009-1943-8
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The medical progress of recent decades has dramatically changed the course of congenital diseases previously considered as lethal in childhood. Thus, cystic fibrosis is now seen as a chronic disease which, due to its various limitations, is classified as a disability; however, with a varying and progressive course. Due to its improved prognosis, death and mortality are no longer the only focus of the disease, but rather therapy of the direct, medico-somatic and increasingly indirect, further and often complex limitations caused by cystic fibrosis. Patient quality of life, as with many other diseases, has become the focal point. Cystic fibrosis patients in particular face a multitude of therapeutic and disease-related limiting factors which stand between them and normality. Caring for this patient group requires a multidisciplinary approach involving a wide range of specialities.
引用
收藏
页码:121 / +
页数:7
相关论文
共 50 条
  • [31] Constipation and cystic fibrosis. Slow movement
    van der Doef, H. P. J.
    Houwen, R. H. J.
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (03) : 385 - 386
  • [32] Bronchial arterial changes in cystic fibrosis.
    Senger, C
    Davidson, G
    Lillquiest, Y
    de Sa, D
    MODERN PATHOLOGY, 2004, 17 (02) : 273 - 273
  • [33] Performances and ergonomics of nebulizers in cystic fibrosis.
    Faurisson, F
    Dessanges, JF
    Grimfeld, A
    Beaulieu, R
    Kitzis, MD
    Peytavin, G
    Lefevre, JP
    Farinotti, R
    Sautegeau, A
    REVUE DES MALADIES RESPIRATOIRES, 1996, 13 (02) : 155 - 162
  • [34] Whole body vibration in cystic fibrosis.
    Roth, J.
    Schnabel, D.
    Wust, M.
    Armbrecht, G.
    Wahn, U.
    Felsenberg, D.
    Staab, D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S295 - S295
  • [35] Clinical pharmacokinetics of antimicrobial drugs in cystic fibrosis.
    D.J. Touw
    Pharmacy World and Science, 1998, 20 : 149 - 160
  • [36] Cystic fibrosis. A short overview for pneumological practice
    Koehnlein, T.
    Welte, T.
    PNEUMOLOGE, 2009, 6 (01): : 41 - 49
  • [37] Neuropsychological impairment in adult patients with cystic fibrosis.
    Epker, JT
    Maddrey, M
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 1999, 14 (01) : 106 - 106
  • [38] Heart-lung transplantation for cystic fibrosis.
    Haloun, A
    Despins, P
    Horeau, D
    Threilhaud, M
    Portier, D
    DeLajartre, AY
    Jegou, B
    AlHabach, O
    Train, M
    Duveau, D
    Caillon, J
    Michaud, JL
    ARCHIVES DE PEDIATRIE, 1996, 3 (05): : 427 - 432
  • [39] Extra-Pulmonary Complications in Cystic fibrosis.
    Cohen-Cymberknoh, Malena
    PEDIATRIC PULMONOLOGY, 2021, 56 : S60 - S61
  • [40] Cystic fibrosis. Disease on the way to personalized therapy
    van Koningsbruggen-Rietschel, S.
    Rietschel, E.
    MONATSSCHRIFT KINDERHEILKUNDE, 2017, 165 (08) : 681 - 687